| 1 | <p>Epidemiological characteristics of and risk factors… (10.2147/bctt.s176070) | Abstract References ORCID | 201.63 | 487 |
| 2 | Triple-negative breast cancer: treatment challenges and solu… (10.2147/bctt.s69488) | Abstract References ORCID | 150.00 | 99 |
| 3 | Acute radiation dermatitis in breast cancer patients: challe… (10.2147/bctt.s109763) | Abstract References ORCID | 138.84 | 70 |
| 4 | PI3K mutations in breast cancer: prognostic and therapeutic… (10.2147/bctt.s60696) | Abstract References ORCID | 138.38 | 69 |
| 5 | Current perspectives on CHEK2 mutations in breast cancer (10.2147/bctt.s111394) | Abstract References ORCID | 132.26 | 57 |
| 6 | Expression and functionality of TRPV1 in breast cancer cells (10.2147/bctt.s121610) | Abstract References ORCID | 128.70 | 51 |
| 7 | Mechanism of metastasis suppression by luteolin in breast ca… (10.2147/bctt.s144202) | Abstract References ORCID | 125.41 | 46 |
| 8 | Benefits of multidisciplinary teamwork in the management of… (10.2147/bctt.s35581) | Abstract References ORCID | 124.71 | 45 |
| 9 | Methods to improve rehabilitation of patients following brea… (10.2147/bctt.s47012) | Abstract References ORCID | 124.71 | 45 |
| 10 | Mastectomy skin flap necrosis: challenges and solutions (10.2147/bctt.s81712) | Abstract References ORCID | 123.99 | 44 |
| 11 | Symptom report in detecting breast cancer-related lymphedema (10.2147/bctt.s87854) | Abstract References ORCID | 120.96 | 40 |
| 12 | Axillary web syndrome following breast cancer surgery: sympt… (10.2147/bctt.s146635) | Abstract References ORCID | 117.62 | 36 |
| 13 | Prevention and treatment of acute and chronic radiodermatiti… (10.2147/bctt.s149752) | Abstract References ORCID | 117.62 | 36 |
| 14 | Structure-based virtual screening and molecular docking for… (10.2147/bctt.s132074) | Abstract References ORCID | 116.72 | 35 |
| 15 | Multidrug-resistant breast cancer: current perspectives (10.2147/bctt.s37638) | Abstract References ORCID | 114.86 | 33 |
| 16 | The incidence rate of female breast cancer in Saudi Arabia:… (10.2147/bctt.s50750) | Abstract References ORCID | 114.86 | 33 |
| 17 | Profile of neratinib and its potential in the treatment of b… (10.2147/bctt.s54414) | Abstract References ORCID | 113.89 | 32 |
| 18 | Oncological safety and cosmetic outcomes in oncoplastic brea… (10.2147/bctt.s113742) | Abstract References ORCID | 112.89 | 31 |
| 19 | Economic burden related to chemotherapy-related adverse even… (10.2147/bctt.s105618) | Abstract References ORCID | 109.68 | 28 |
| 20 | Optical imaging for breast cancer prescreening (10.2147/bctt.s51702) | Abstract References ORCID | 109.68 | 28 |
| 21 | Exercise after breast cancer treatment: current perspectives (10.2147/bctt.s82039) | Abstract References ORCID | 109.68 | 28 |
| 22 | Reducing infection risk in implant-based breast-reconstructi… (10.2147/bctt.s97764) | Abstract References ORCID | 107.35 | 26 |
| 23 | <p>Targeting stem cells in the realm of drug-resistant… (10.2147/bctt.s189224) | Abstract References ORCID | 106.12 | 25 |
| 24 | Optimal management of bone metastases in breast cancer patie… (10.2147/bctt.s6655) | Abstract References ORCID | 104.85 | 24 |
| 25 | Establishment and characterization of a receptor-negative, h… (10.2147/bctt.s74509) | Abstract References ORCID | 102.13 | 22 |
| 26 | Hypofractionated whole breast radiotherapy: current perspect… (10.2147/bctt.s81710) | Abstract References ORCID | 102.13 | 22 |
| 27 | High glucose levels promote the proliferation of breast canc… (10.2147/bctt.s135665) | Abstract References ORCID | 100.68 | 21 |
| 28 | Current advances in biomarkers for targeted therapy in tripl… (10.2147/bctt.s114659) | Abstract References ORCID | 99.17 | 20 |
| 29 | Discordance of the estrogen receptor and HER-2/neu in breast… (10.2147/bctt.s137709) | Abstract References ORCID | 99.17 | 20 |
| 30 | Eribulin (Halaven): a new, effective treatment for women wit… (10.2147/bctt.s21741) | Abstract References ORCID | 99.17 | 20 |
| 31 | Palbociclib: an evidence-based review of its potential in th… (10.2147/bctt.s46725) | Abstract References ORCID | 99.17 | 20 |
| 32 | Artificial intelligence methods for the diagnosis of breast… (10.2147/bctt.s175311) | Abstract References | 97.22 | 87 |
| 33 | Statins and risk of breast cancer recurrence (10.2147/bctt.s116694) | Abstract References ORCID | 95.91 | 18 |
| 34 | Tamoxifen for women at high risk of breast cancer (10.2147/bctt.s43763) | Abstract References ORCID | 94.15 | 17 |
| 35 | Breast cancer in Brazil: epidemiology and treatment challeng… (10.2147/bctt.s50361) | Abstract References ORCID | 92.28 | 16 |
| 36 | Candidate prognostic markers in breast cancer: focus on extr… (10.2147/bctt.s46020) | Abstract References ORCID | 90.31 | 15 |
| 37 | Silicone-induced granuloma of breast implant capsule (SIGBIC… (10.2147/bctt.s126003) | Abstract References ORCID | 88.21 | 14 |
| 38 | Imprint cytology versus frozen section analysis for intraope… (10.2147/bctt.s130987) | Abstract References ORCID | 88.21 | 14 |
| 39 | Dormancy in breast cancer (10.2147/bctt.s26431) | Abstract References ORCID | 88.21 | 14 |
| 40 | Current and emerging quantitative magnetic resonance imaging… (10.2147/bctt.s35882) | Abstract References ORCID | 88.21 | 14 |
| 41 | Cardiac risk in the treatment of breast cancer: assessment a… (10.2147/bctt.s47227) | Abstract References ORCID | 88.21 | 14 |
| 42 | Triple negative breast cancer: an Indian perspective (10.2147/bctt.s85442) | Abstract References ORCID | 88.21 | 14 |
| 43 | <em>Ulva lactuca</em> polysaccharides prevent Wi… (10.2147/bctt.s125165) | Abstract References | 87.79 | 56 |
| 44 | Anticancer and cardio-protective effects of liposomal doxoru… (10.2147/bctt.s170239) | Abstract References | 86.21 | 52 |
| 45 | Modulation of breast cancer cell viability by a cannabinoid… (10.2147/bctt.s100393) | Abstract References ORCID | 85.96 | 13 |
| 46 | Drug-screening and genomic analyses of HER2-positive breast… (10.2147/bctt.s115600) | Abstract References ORCID | 85.96 | 13 |
| 47 | Impact of semaphorin expression on prognostic characteristic… (10.2147/bctt.s135753) | Abstract References ORCID | 85.96 | 13 |
| 48 | Aromatase inhibitors in the treatment of breast cancer in po… (10.2147/bctt.s22905) | Abstract References ORCID | 85.96 | 13 |
| 49 | Role of lapatinib alone or in combination in the treatment o… (10.2147/bctt.s29996) | Abstract References ORCID | 85.96 | 13 |
| 50 | The role of peroxiredoxin II in chemoresistance of breast ca… (10.2147/bctt.s61281) | Abstract References ORCID | 85.96 | 13 |